免疫编辑
生物
免疫系统
细胞因子
免疫学
干扰素
先天免疫系统
获得性免疫系统
癌症
癌症研究
免疫疗法
遗传学
作者
Hiroaki Ikeda,Lloyd J. Old,Robert D. Schreiber
标识
DOI:10.1016/s1359-6101(01)00038-7
摘要
Interferon-gamma (IFNγ) is a cytokine that plays physiologically important roles in promoting innate and adaptive immune responses. The absence of IFNγ production or cellular responsiveness in humans and experimental animals significantly predisposes the host to microbial infection, a result that validates the physiologic importance of this cytokine in preventing infectious disease. Recently, an additional role for IFNγ in preventing development of primary and transplanted tumors has been identified. Although there now appears to be a consensus that IFNγ promotes host responses to tumors, the mechanisms by which this cytokine achieves its effects remain unclear. In this review, we briefly discuss key issues of the molecular cell biology of IFNγ and its receptor that are most relevant to IFNγ-dependent anti-tumor effects and then focus on the data implicating IFNγ as a critical immune system component that regulates tumor development. Potential mechanisms underlying IFNγ’s anti-tumor effects are discussed and a preliminary integrative model of IFNγ’s actions on tumors is proposed. Finally, the capacity of IFNγ and lymphocytes to not only provide protection against tumor development but also to sculpt the immunogenic phenotype of tumors that develop in an immunocompetent host is presented and introduced as a “cancer immunoediting” process.
科研通智能强力驱动
Strongly Powered by AbleSci AI